1. Home
  2. Companies
  3. Alloy Therapeutics
AT

Alloy Therapeutics

About

Alloy Therapeutics is a biotechnology ecosystem company on a mission to democratize access to foundational drug discovery technologies and services. Founded in 2017, Alloy empowers the global scientific community - from academic labs to biopharma giants - to discover and develop better biologics together. The company has built an integrated platform spanning multiple therapeutic modalities: antibodies and bispecifics, TCR mimics, genetic medicines, and cell therapies. By embedding AI/ML directly into discovery workflows and combining it with one of the industry's largest proprietary experimental datasets, Alloy shortens design cycles, improves prediction accuracy, and enables partners to move from concept to human data with unprecedented speed and capital efficiency.

What truly sets Alloy apart is its commitment to open access and reinvestment. With 100% of profits invested back into future innovation, the company continuously pushes the boundaries of science to deliver groundbreaking solutions. Alloy's 100+ scientists across global labs in Waltham, MA; Athens, GA; Cambridge, UK; Basel, Switzerland; and Fujisawa, Japan bring deep expertise to tackle the hardest drug discovery challenges. The company operates with a partner-first philosophy, offering flexible collaboration models that put the best drugs to patients faster - because at Alloy, they believe the industry should compete on therapeutic outcomes, not exclusive access to platforms.

Similar companies

XT

Xaira Therapeutics

In 2023, a group of visionary scientists and investors recognized that drug discovery remained an expensive, time-consuming process with high failure rates. Despite advances in AI, the pharmaceutical industry was still struggling to translate computational insights into viable medicines. This realization sparked the creation of Xaira Therapeutics - co-founded and incubated by ARCH Venture Partners and Foresite Labs - to build an integrated biotechnology company that would truly harness the transformative power of artificial intelligence for drug discovery. Built on the groundbreaking protein design work of Nobel Laureate Dr. David Baker and his team at the University of Washington's Institute for Protein Design, Xaira brings together advanced AI research, expansive data generation, and robust therapeutic product development. The company emerged from stealth mode in 2024 with over $1 billion in funding, ready to revolutionize how we treat disease by making predictions about the right biology to target, the best therapeutics to modulate those targets, and the patients who will benefit most. With offices in South San Francisco, Seattle, and London, Xaira is shifting drug discovery from an empirical science to a precise engineering discipline.

PT

Prime Therapeutics LLC

We're a pharmacy solutions company that helps people get the medicine they need to feel better and live well. Founded in 1998 by Blue Cross and Blue Shield plans, we've grown into a diversified pharmacy organization that serves millions of people across the country. Our team focuses on delivering real value through pharmacy benefit management, specialty pharmacy services, and clinical programs that actually make a difference in people's lives. What makes us different is that we're owned by health plans, not Wall Street. This means we can focus on what matters - helping our members access affordable medications while supporting better health outcomes. We work with health plans, employers, and government programs to create pharmacy solutions that combine clinical expertise with modern technology. From managing specialty drugs for complex conditions to helping people understand their prescription benefits, we're here to make pharmacy care simpler and more effective for everyone we serve.

PC

Prowess Consulting

For over 20 years, we've partnered with enterprises, technology companies, financial institutions, and credit unions to help them turn data into decisions and decisions into growth. We deliver strategic guidance and outsourced services across Data and AI, Software Engineering, Content, and Marketing, embedding Agentic AI into every engagement to streamline operations, enhance decision-making, and optimize results. Our core team of over 100 engineers, content creators, writers, designers, and strategists are data and AI, communication, technology, and marketing experts working from Seattle and India. We combine technical expertise, strategic insight, and AI capabilities to help organizations build production-ready systems that scale - from data foundations and automation to compliance programs and competitive content strategies.

OS

Obsidian Security

In 2017, Obsidian Security was created to close a critical gap: securing the SaaS applications where modern business happens. The founders recognized that while enterprises had focused heavily on securing cloud infrastructure and endpoints, SaaS sprawl had exposed an enormous security vulnerability where users, data, and business operations actually live. Obsidian set out to build the first truly comprehensive security solution for SaaS environments. Backed by top investors including Greylock Partners, Norwest Venture Partners, GV, Wing, and IVP, Obsidian has built a complete SaaS security platform that combines application posture management with identity and data protection to prevent, detect, and mitigate threats across the entire kill chain. The platform provides real-time visibility into SaaS environments, detects deviations from normal behavior that can indicate account compromise or insider threats, and responds to risks as they happen. Today, Obsidian is trusted by global enterprises including Snowflake, T-Mobile, Pure Storage, and protects more than 200 organizations across North America, Europe, the Middle East, Southeast Asia, Australia, and New Zealand. The company's leadership team includes industry veterans who helped define the categories of endpoint and identity security at CrowdStrike, Okta, Cylance, and Carbon Black.

AX

Axmed

Over 80% of the world's population lives in low- and middle-income countries (LMICs), yet these regions account for less than 6% of global pharmaceutical revenue, leaving hundreds of millions without access to essential medicines. Axmed exists to change this reality. Through a technology-driven B2B marketplace, the company connects healthcare procurers directly with trusted pharmaceutical suppliers, eliminating the fragmented systems that keep medicines out of reach and creating a transparent, efficient procurement ecosystem. As a social impact venture, Axmed operates with radical transparency - capping markups at 10% in an industry where 250% is commonplace and redeploying 30% of profits back into the health systems served. Since launching the platform, Axmed has reached 4.2 million patients, achieved 35% average cost savings on medicines, and built a network of 130+ active procurers and suppliers across 5,000 products. With headquarters in Switzerland and regional operations in Nairobi, the company combines cutting-edge technology with strategic partnerships to accelerate equitable access to medicines for the 6.5 billion people who need them most.

OT

Ovations Technologies

Ovations Technologies (Pty) Ltd is a leader in hyper-automation and digital transformation, with over 25 years of experience enabling the digital enterprise. As an IBM Gold Partner with proficient expertise across all IBM Automation products, we combine deep technical knowledge with strategic business insight to deliver measurable results. Our seven integrated value propositions - Strategic Portfolio Management, Advanced Integration Solutions, Client Lifecycle Management & GRC, Data & Insights, Digital Solutions, Enterprise Hyper Automation, and Agentic AI - help organizations transform strategy into execution with consistency, agility, and measurable outcomes. With core domain expertise in process automation, content services, data & analytics, and financial crime and risk prevention solutions, Ovations has established itself as a trusted technology partner across Africa. We partner with leading global technology providers including IBM, AWS, and Atlassian to deliver enterprise-grade solutions that help clients modernize infrastructure, adopt AI-driven capabilities, and optimize operations with cloud, automation, and analytics. From advising on digital enablement to delivering scalable technology solutions and sourcing top ICT talent, our work transforms complex business challenges into measurable success.